Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
3,621 total articles
Intuitive Machines Chief Accounting Officer and Controller Steven Vontur sold 4,343 shares of Class A common stock on February 11, 2026, at $17.436 per share, netting $75,724. The sale, intended to satisfy tax withholding tied to restricted stock unit vesting, was non-discretionary. The transaction comes amid broader industry developments, includin…
Intuitive Machines' senior technology executive, Timothy Price Crain II, sold 23,226 Class A shares on February 11, 2026, raising $404,968 to satisfy tax withholding tied to vested restricted stock units. The non-discretionary sale leaves Crain with 359,726 shares. The stock trades at a premium to its InvestingPro Fair Value estimate and follows th…
Intuitive Machines SVP and CFO Peter McGrath disposed of 25,541 shares of Class A common stock on February 11, 2026, raising about $445,332 to meet tax-withholding requirements tied to restricted stock units. The sale was not a discretionary trade. Recent volatility in LUNR shares and several industry developments - including a $1.25 trillion merge…
Mitsui Sumitomo Insurance Co. Ltd., a roughly 10% holder of W.R. Berkley Corp. (WRB), purchased $2.8 million of common stock across multiple trades on February 12-13, 2026 under a pre-arranged Rule 10b5-1 plan adopted in October 2025. The purchases spanned prices between $69.7349 and $72.7573 and increase the company’s direct stake to 56,596,652 sh…
Mitchell Lawrence Jones, Chief Medical Officer of Palisade Bio, sold 1,989 shares at $1.75 on February 12, 2026, to satisfy tax-withholding tied to RSU vesting. Jones also received 8,000 shares via settlement of vested RSUs on February 11, 2026, and now directly owns 13,263 shares, including 3,400 acquired under the company ESPP. The company has re…
Avidbank Holdings director Mike Rosinus sold 1,063 shares on February 11, 2026, at $30.45 per share for proceeds of $32,368. The sale comes while the stock trades near $30 and has recorded a 26% gain over the past six months. Following the trade, Rosinus holds both indirect and direct stakes in the bank through PTMR Capital Partners LP and personal…
John David Finley, who serves as both CEO and CFO of Palisade Bio, executed a sale of 3,896 shares of the company’s common stock on February 12, 2026, for $1.75 per share. The transaction followed a one-day sequence in which Finley acquired 13,333 shares from vested restricted stock units and exercised associated options at a zero strike. Separatel…
Naftali Holtz, chief financial officer of Royal Caribbean Cruises Ltd. (RCL), sold 43,121 shares of the company on February 13, 2026, for roughly $16.7 million, according to a Form 4 filing. The same filing records a gift of 750 shares and shows Holtz retains 28,116 shares directly. The sale follows the company's Q4 2025 financial results that met …
Michael W. Bayley, President and CEO of Royal Caribbean International, sold 79,894 shares of Royal Caribbean Cruises Ltd. common stock in a set of transactions on February 13, 2026, at prices between $322.66 and $332.19 for a total of $26,145,463. After the disposals, Bayley retains direct ownership of 58,108 shares. Separately, Royal Caribbean rep…
Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals (IONS), sold 15,642 shares on February 13, 2026, in two transactions totaling roughly $1.27 million under a Rule 10b5-1 plan. The stock has risen sharply over the past year and is trading near its 52-week high as the company reports several clinical and regulatory achievemen…
Lynne Parshall, a director at Ionis Pharmaceuticals (IONS), sold 5,000 shares on February 11, 2026, for $413,588 under a Rule 10b5-1 plan. The transaction occurred while the stock trades close to its 52-week high and follows several regulatory and clinical advances for the company that have attracted positive analyst attention.
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 14,676 shares of the companys common stock for roughly $569,809 across February 12 and 13, 2026, while exercising options to acquire 14,056 shares valued at $102,340. The trades were executed under a Rule 10b5-1 plan adopted October 6, 2025. Separately, the companys lead candidat…
On February 11, 2026, the spouse of Symbotic director Ford Rollin L indirectly sold 41,100 shares of Symbotic Class A common stock for roughly $3.45 million in several transactions. The same day, related trusts redeemed Symbotic Holdings Units for Class A shares and sold a portion of those shares. Separately, Symbotic reported Q1 FY2026 results sho…
A director at Kratos Defense & Security Solutions sold 5,000 shares on February 12, 2026, under a previously established 10b5-1 trading schedule. The company also announced contracts and facility expansions tied to automated trucking, a Pentagon drone program, and hypersonic testing, while an equity analyst raised its price target and maintained a …
Vincent Retort, Executive Vice President at Lumentum Holdings Inc (LITE), sold 44,420 shares on February 12, 2026, through multiple transactions under a pre-arranged Rule 10b5-1 trading plan, generating roughly $26.6 million. The sales occurred while Lumentum's shares have jumped 624% over the prior year and trade near their 52-week high; recent qu…
Revolve Group Inc. co-Chief Executive Officer Michael Karanikolas, through MMMK Development, Inc., sold 17,593 shares of Class A Common Stock on February 11 and 12, 2026, for about $459,315 under a Rule 10b5-1 plan. The same entity converted an equal number of Class B shares to Class A on those dates. After the transactions, Karanikolas directly ho…
Mmmk Development, a 10% shareholder of Revolve Group, Inc. (RVLV), sold 17,593 Class A shares for about $459,315 in two tranches, according to a Form 4 filing with the Securities and Exchange Commission. The transactions occurred on February 11 and 12, 2026, and followed conversions of Class B into Class A shares. The sale coincides with recent sto…
Michael Mente, co-chief executive of Revolve Group, completed the sale of 17,593 Class A shares on February 11-12, 2026, at a weighted average price between $25.86 and $26.83, raising roughly $459,315. The transactions coincided with a share conversion of an equal number of shares from Class B to Class A at no cost, and follow a recent company reta…
Stacey L. Amundson, Executive Vice President and Chief Human Resources Officer of Patrick Industries (PATK), sold 3,903 common shares on February 12, 2026, receiving $568,334 at a weighted average price of $145.6148. The trade left Amundson with 12,819 shares. The transaction comes after Patrick Industries reported fourth-quarter 2025 adjusted EPS …
Reynal Vicente, Chairman, President and CEO of Ingersoll Rand Inc. (NYSE: IR), sold 440 shares on February 11, 2026, for $100 each and simultaneously exercised options to acquire 440 shares at $10.61. The transactions took place as the stock traded near its 52-week high, and follow a quarter in which the company beat analyst estimates on both reven…
Eric J. Bartko, Senior Vice President and Chief Customer Officer of Murphy USA Inc (NYSE: MUSA), carried out a series of stock transactions on February 11 and February 13, 2026, including a sale of 345 shares on Feb. 13 and multiple disposals and grants on Feb. 11. These trades occurred in the wake of Murphy USA's fourth-quarter 2025 results, which…
Cummins Inc. director William I. Miller sold 18,042 shares on February 11, 2026, generating $10,811,645 in proceeds. The company also announced a $2.00 quarterly cash dividend payable March 5, 2026. Cummins reported adjusted fourth-quarter EPS of $5.81 and EBITDA of $1.4 billion, both ahead of estimates, prompting several analysts to lift price tar…
Thomas W. Powell, a 10% owner of Powell Industries (POWL), sold 24,916 shares of common stock between February 11 and February 13, 2026, generating $15,126,884 in proceeds. The disposals occurred in several transactions at prices from $592.2739 to $602.575. After the sales Powell still holds 651,949 shares directly and indirectly controls additiona…
WEX Inc.'s Chief Operating Officer, Robert Joseph Deshaies, exercised options and sold the resulting shares on February 11, 2026, realizing proceeds of $171,312 from the sale and $79,670 from the option exercise. The transactions leave Deshaies with 15,699 shares. Separately, WEX reported better-than-expected fourth-quarter 2025 results, though the…
Auburn OWMH, LLLP, part of a group owning at least 10% of OneWater Marine Inc (NASDAQ: ONEW), purchased $307,501 of the company’s Class A common shares across two transactions in February 2026. The purchases raise the entity’s direct stake to 779,776 shares. Separately, OneWater reported Q1 FY2026 results that exceeded EPS and revenue expectations …
